Tuesday, February 14, 2017 9:25:45 AM
Company has put out a couple news releases since and reacting to the investigation. Apparently it is routine for the CEO of a company under investigation there to be brought in and questioned - so that was not as red a flag as it first appeared (call it a pink flag). They also stressed the number of outside groups involved in the testing, dropping as many British organizations into the PR as they could.
The bottom line in these PRs was that they stood by their data and reiterated their intent to file for a US NDA in Q1 2017.
If I could afford to buy all of them, I would not need to buy any of them and I sure wouldn't be spending time on the message boards!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM